866-997-4948 (US-Canada Toll Free)

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency

Published Date : 2014-02-04

Category :

Pharmaceutical

No. of Pages : 206

Product Synopsis

The life sciences BPO market comprises services offered by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies.  Pharmaceutical companies are now forming long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for... Read More

Table Of Content

Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019)
2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)

Chapter 3 Global Life Sciences BPO Market Dynamics
3.1 Introduction
3.1.1 Drivers
3.1.1.1 Rising cost of R&D and decline in productivity
3.1.1.2 Patent expirations to boost CMO industry growth
3.1.1.3 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions
3.1.1.4 Restructuring of pharmaceutical production
3.1.2 Restraints
3.1.2.1 Data safety concerns
3.1.2.2 Stringent and varied regulatory approval processes in different countries
3.1.2.3 Unforeseen Costs has marred the growth of CRO industry
3.1.3 Opportunities
3.1.3.1 Biologics
3.1.3.2 Emerging markets
3.2 Value Chain Analysis
3.2.1 People Skills and Challenges for Life Sciences BPO Services:
3.2.2 Pharmaceutical Outsourcing
3.2.3 Contract Research Outsourcing Market:
3.2.4 Value Chain Analysis: Contract Research Outsourcing Market
3.2.5 Contract Research Outsourcing Services (%), 2012
3.2.5.1 Contract Research Outsourcing Services (%), 2012
3.2.6 Pharmacovigilance
3.2.6.1 Value Chain Analysis: Pharmacovigilance
3.2.7 Biostatistics
3.2.7.1 Value Chain Analysis: Biostatistics
3.2.8 Risk-based Monitoring
3.2.8.1 Value Chain Analysis: Risk based Monitoring
3.2.9 Study Design and Protocol Development
3.2.9.1 Value Chain Analysis: Study Design and Protocol Development
3.2.10 Medical Writing
3.2.10.1 Value Chain Analysis: Medical Writing
3.2.11 Clinical Data Management
3.2.11.1 Value Chain Analysis: Clinical Data Management
3.2.12 Site Management
3.2.12.1 Value Chain Analysis: Site Management
3.2.13 Regulatory Services
3.2.13.1 Value Chain Analysis: Regulatory Services
3.3 Porter’s Five Force Analysis: Global Life sciences BPO Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography
3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe
3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography

Chapter 4 Global Life Sciences BPO Market, by Segments
4.1 Overview
4.2 Pharmaceutical Outsourcing
4.2.1 Contract Manufacturing Outsourcing
4.2.1.1 Active Pharmaceutical Ingredients (API) Manufacturing
4.2.1.1.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
4.2.1.2 Final Dosage Form (FDF) Manufacturing
4.2.1.2.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
4.2.1.3 Packaging
4.2.1.3.1 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
4.2.2 Contract Research Outsourcing
4.2.2.1 Drug Discovery
4.2.2.1.1 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.2 Pre-Clinical Studies
4.2.2.2.1 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.3 Early Phase Clinical Research Services (Phase I / IIa)
4.2.2.3.1 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.4 Phase IIb / IIIa
4.2.2.4.1 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.5 Phase IIIb / IV (Peri/Post Approval Phase / Post Marketing Surveillance)
4.2.2.5.1 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.6 Medical Writing
4.2.2.6.1 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.7 Pharmacovigilance
4.2.2.7.1 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.8 Clinical Data Management
4.2.2.8.1 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.9 Regulatory Services
4.2.2.9.1 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.10 Clinical Monitoring
4.2.2.10.1 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.11 Biostatistics
4.2.2.11.1 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.12 Protocol Development
4.2.2.12.1 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.13 Site Management
4.2.2.13.1 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)

Chapter 5 Global Life Sciences BPO Market, by Geography
5.1 Overview
5.1.1 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
5.1.2 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.2 Germany
5.3.2.1 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.2.2 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.2.3 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.3.2 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2-019 (USD Billion)
5.3.3.3 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.4 France
5.3.4.1 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.4.2 France Contract Manufacturing Outsourcing Service Market, 2011 – 2019 (USD Million)
5.3.4.3 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.5.2 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.5.3 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.6.2 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.6.3 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.7 Switzerland
5.3.7.1 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.7.2 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.7.3 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.8 Rest of Europe (ROE)
5.3.8.1 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.8.2 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.8.3 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.5 RoW
5.5.1 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

Chapter 6 Global Life Sciences BPO Market Share Analysis
6.1 Market Share Analysis by Key Players of Global CRO Market
6.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%)
6.2 Market Share Analysis by Key Players of Global CMO Market
6.2.1 Global CMO Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Success Strategies
7.1.1 Expand Market into Emerging Countries
7.1.2 Ensure Data Confidentiality and Regulatory Compliance
7.1.3 Timely Entry in the Market
7.1.4 Offer a Wide Range of Research and Manufacturing Services
7.1.5 Developing Strategic Alliances and Partnerships With Pharmaceutical and Biotechnology Companies
7.1.6 Risk Management

Chapter 8 Company Profiles
8.1 Accenture, Plc
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.4.1 Mergers and acquisitions
8.1.5 Recent Developments
8.2 Boehringer Ingelheim GmbH
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.4.1 Research And Development For Medical Innovation
8.2.5 Recent Developments
8.3 Catalent Pharma Solutions, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.4.1 Geographical expansion of business
8.3.4.2 Diversification of product portfolio
8.3.5 Recent Developments
8.4 Charles River Laboratories International, Inc. (CRL)
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.4.1 Expansion of services offered
8.4.4.2 New product launches and Innovation
8.4.4.3 Strategic acquisitions
8.4.5 Recent Developments
8.5 Cognizant Technology Solutions
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.4.1 Expansion of geographical footprint
8.5.4.2 Expansion product portfolio
8.5.4.3 Highly-skilled manpower
8.5.4.4 Strategic acquisitions
8.5.5 Recent Developments
8.6 Covance, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.4.1 New product development and innovation
8.6.4.2 Agreements and collaborations
8.6.4.3 Strategic acquisitions
8.6.4.4 Geographical expansion of business
8.6.5 Recent Developments
8.7 DSM
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.4.1 Strategic acquisitions
8.7.5 Recent Developments
8.8 Fareva
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Business Strategies
8.8.3.1 Extensive product portfolio
8.8.3.2 Safety environment for staff
8.8.3.3 Commitment to quality
8.8.4 Recent Developments
8.9 ICON, Plc
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.4.1 Business expansion in APAC region
8.9.4.2 Expansion of services offered
8.9.5 Recent Developments
8.10 Infosys
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.4.1 Extensive product portfolio
8.10.4.2 Geographical expansion of business
8.10.5 Recent Developments
8.11 International Business Machines Corporation
8.11.1 Company overview
8.11.2 Financial overview
8.11.3 Product Portfolio
8.11.4 Business strategies
8.11.4.1 Focus on increasing facilities for predictive analytics
8.11.4.2 Geographic Expansion
8.11.5 Recent developments
8.12 Lonza Group
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.4.1 Investment in emerging economies
8.12.4.2 Mergers and acquisitions
8.12.5 Recent Developments
8.13 Pharmaceutical Product Development, Inc. (PPD, Inc.)
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.4.1 Expanding geographic presence
8.13.4.2 Incorporation of innovative technologies
8.13.4.3 Strategic acquisitions
8.13.4.4 New product launch and innovation
8.13.5 Recent Developments
8.14 Parexel International Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.4.1 Strong presence in Asia and emerging markets
8.14.4.2 Strategic alliances
8.14.4.3 Mergers & Acquisitions
8.14.5 Recent Developments
8.15 Patheon, Inc.
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
8.15.4.1 Strategic acquisitions
8.15.4.2 Geographical expansion of business
8.15.5 Recent Developments
8.16 Piramal Healthcare
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Business Strategies
8.16.4.1 Expansion of services offered
8.16.5 Recent Developments
8.17 PRA International, Inc.
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Business Strategies
8.17.4.1 Mergers and acquisitions
8.17.5 Recent Developments
8.18 Quintiles Transnational Corporation
8.18.1 Company Overview
8.18.2 Financial Overview
8.18.3 Product Portfolio
8.18.4 Business Strategies
8.18.4.1 Expansion of services
8.18.4.2 Acquisitions and partnerships
8.18.4.3 Innovation in services offered
8.18.5 Recent Developments
8.19 Wipro Limited
8.19.1 Company Overview
8.19.2 Financial Overview
8.19.3 Product Portfolio
8.19.4 Business Strategies
8.19.4.1 Geographical Expansion

Chapter 9 List of the Companies
9.1 List of Companies Offering Contract Research Outsourcing Services in North America.
9.3 List of Companies Offering Contract Research Outsourcing Services in Europe.
9.3.1 List of Contract Research Organizations in France
9.3.2 List of Contract Research Organizations in Italy
9.3.4 List of Contract Research Organizations in Germany
9.3.5 List of Contract Research Organizations in Spain
9.3.6 List of Contract Research Organizations in United Kingdom
9.3.7 List of Contract Research Organizations in Switzerland

List of Tables

List of Tables

TABLE 1 Market Snapshot : Life Sciences BPO Market
TABLE 2 Research and Development Spending per New Drug (2012)
TABLE 3 Global Life Sciences BPO Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 4 Global Pharmaceutical Contract Manufacturing Outsourcing (CMO) Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 5 Global Contract Research Outsourcing Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 6 Outsourced Drug Discovery and Development Expenditures, by Types, USD Billion
TABLE 7 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
TABLE 8 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 9 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 10 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 11 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 12 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 13 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 14 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 15 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 16 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 17 France Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 18 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 19 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 20 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 21 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 22 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 23 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 24 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 25 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 26 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 27 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 28 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 29 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 30 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 31 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 32 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

List of Figures

List of Figures

FIG. 1 Global Life Sciences BPO Services : Market Segmentation
FIG. 2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
FIG. 3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 5 Global Life Sciences BPO Market: Drivers and Restraints
FIG. 6 Value Chain Analysis: Pharmaceutical Outsourcing
FIG. 7 Value Chain Analysis: Contract Research Outsourcing Market
FIG. 8 Contract Research Outsourcing Services (%), 2012
FIG. 9 Value Chain Analysis: Pharmacovigilance
FIG. 10 Value Chain Analysis: Biostatistics
FIG. 11 Value Chain Analysis: Risk based Monitoring
FIG. 12 Value Chain Analysis: Study Design and Protocol Development
FIG. 13 Value Chain Analysis: Medical Writing
FIG. 14 Value Chain Analysis: Clinical Data Management
FIG. 15 Value Chain Analysis: Site Management
FIG. 16 Value Chain Analysis: Regulatory Services
FIG. 17 Porter’s Five Force Analysis: Global Life sciences BPO Market
FIG. 18 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
FIG. 19 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012
FIG. 20 Pharmaceutical Contract Manufacturing Outsourcing, Flow of Services
FIG. 21 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 22 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 23 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
FIG. 24 Pharmaceutical Contract Research Outsourcing, Flow of Services
FIG. 25 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 26 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 27 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 28 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 29 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 30 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 31 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 32 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 33 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 34 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 35 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 36 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 37 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 38 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
FIG. 39 Global CRO: Market Share, by Key Players, 2012 (%)
FIG. 40 Global CMO: Market Share, by Key Players, 2012 (%)
FIG. 41 Accenture, Plc.: Annual Revenue (USD Billion) 2010 – 2012
FIG. 42 Boehringer Ingelheim GmbH: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 43 Catalent Pharma Solutions, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 44 Charles River Laboratories International, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 45 Cognizant Technology Solutions: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 46 COVANCE, Inc.: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 47 DSM: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 48 ICON, PLC: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 49 Infosys: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 50 IBM Corporation: Annual Revenue (USD Billion) 2010 – 2012
FIG. 51 Lonza Group: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 52 Parexel International Corporation: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 53 Patheon, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 54 Piramal Healthcare: Annual Sales Revenue, USD Million (2010 – 2012)
FIG. 55 Quintiles Transnational Corporation: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 56 Wipro Limited: Annual Revenue (USD Million) 2010 – 2012

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Neuroendoscopy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Neuroendoscopes are rigid endoscopes applied for minimally invasive diagnostic and therapeutic procedures of the brain and spinal cord. The endoscopy devices market is one of the most impactful device markets today that ushered the minimally invasive procedures into the world. This segment encompasses the global market of neuroendoscopes used over the world for procedures such as ventriculostomies, biopsies, removal of cysts, tumors and other obstructions. According to American Brain Tumor Association and National Cancer Institute, the number of cases for CNS tumors in United...

  • Diagnostic Electrocardiograph (DECG) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018

    By - Transparency

    An electrocardiograph is a non-invasive diagnostic device which is used in measuring the electrical activity of the heart. It is primarily used for the detection of cardiac problems in the patient. The global diagnostic electrocardiograph (DECG) market will undergo fair growth in the near future owing to factors such as the need for early detection of diseases, rise in incidence of lifestyle related diseases and increase in the standard of healthcare services. Due to  improvements in the field of medical technology, errors in diagnosis of diseases have been considerably...

  • Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    Gene therapy involves use of DNA as a pharmaceutical agent to treat diseases. It is one of the most important developments in the field of medicine that has potential to treat various lethal diseases such as HIV, cancer and cystic fibrosis. In the long run, biotechnology and clinical trial industries will benefit from developments in gene therapy and provide potential treatment solutions for various incurable diseases.  In the present scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital...